Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
What Makes the Coventry Network Different Than Other Networks?
The network solutions we offer range from broad-based to state certified, outcomes-based solutions and more.
Enlyte Honored with Two Stevie® Awards at 2023 American Business Awards®
Enlyte was today named the winner of a Gold Stevie® Award in the Best E-Book category and a Bronze Stevie® Award in the Achievement in Management category in The 21st Annual American Business Awards® today.
How One Insurance Carrier Reduced Costs to Pay Medical Bills By 92%
A large insurance carrier reduced paper payment processing costs by 92%
Guide to Selecting an Electronic Payments Vendor
Our guide provides all the information you need to evaluate electronic payment solutions.
Enlyte Releases Part 1 of Annual Pharmacy Solutions Drug Trends Report
Efforts to curtail overprescribing of opioids are seemingly having a positive impact in workers’ comp, while increases in costly topical and migraine medications are driving pharmacy spend.
Guide to Selecting an Electronic Payments Vendor
Our guide provides all the information you need to evaluate electronic payment solutions.